Hubei Jumpcan Pharmaceutical Co., Ltd. Hubei Jumpcan Pharmaceutical Co., Ltd.

Hubei Jumpcan Pharmaceutical Co., Ltd.

600566

शेयरों में रैंक #4335
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
शेयर मूल्य
$3.87
मार्केट कैप
$3.57B
बदलाव (1 दिन)
-1.64%
बदलाव (1 वर्ष)
9.08%
देश
CN
व्यापार Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)

श्रेणी

Healthcare
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) के लिए राजस्व
Oct 2026 में राजस्व TTM: 0
Hubei Jumpcan Pharmaceutical Co., Ltd. की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) 0 है। 2026 में, कंपनी ने 0 का राजस्व अर्जित किया जो 2026 के 0 के राजस्व से के बराबर है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
Hubei Jumpcan Pharmaceutical Co., Ltd. के लिए 2001 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
वर्ष राजस्व परिवर्तन
2025 $888.83M -19.07%
2024 $1.10B -19.47%
2023 $1.36B 4.58%
2022 $1.30B 8.64%
2021 $1.20B 27.21%
2020 $943.71M -5.31%
2019 $996.65M -4.89%
2018 $1.05B 20.84%
2017 $867.17M 28.71%
2016 $673.77M 16.12%
2015 $580.22M 20.34%
2014 $482.15M 19.49%
2013 $403.51M 31.04%
2012 $307.92M 707.24%
2011 $38.14M 6.17%
2010 $35.93M 10.48%
2009 $32.52M 4.19%
2008 $31.21M 4.28%
2007 $29.93M 16.41%
2006 $25.71M 17.82%
2005 $21.82M 23.58%
2004 $17.66M 28.84%
2003 $13.71M 5.73%
2002 $12.96M -5.87%
2001 $13.77M 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
कंपनी राजस्व राजस्व में अंतर देश
- -
DE
- -
DE
- -
JP
- -
CH
$6.61B -
IN